Monday, November 2, 2026

How Korea’s ONE Team Aims to Conquer Thailand’s Booming Pharmaceutical Sector

The South Korean government forms a Pharmaceutical Bio ONE Team to enhance exports and market entry in Thailand's pharmaceutical sector.

Miraculous Recovery: U.S. Army Baby Overcomes Heart Defect After Emergency Surgery

A U.S. military family's baby, who underwent emergency heart surgery at two months, has recovered and attended their first outpatient visit.

6 Out Of 16 Host Cities At High Risk: 2026 World Cup Faces War Against Extreme Heat

Extreme heat poses risks for the 2026 World Cup, prompting safety measures for players and fans amid high temperatures.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

A Record Year in China Is Giving Hanmi Pharmaceutical More Firepower for What’s Next

Hanmi Pharmaceutical's Chinese subsidiary surpassed $290M in sales, contributing significantly to the group's growth and future investments.

Samjin Pharm Just Made a Move That Could Shake Up the Alzheimer’s Treatment Market

Samjin Pharmaceutical launches Newtoin Duo Tab, a dual-action Alzheimer’s treatment, enhancing medication adherence for patients.

Samsung Biologics Just Made a Big Move That Could Reshape Korea’s Biotech Future

Samsung Biologics reveals C-Lab Outside, a biotech innovation hub, to support startups and foster growth in Korea's biotech sector.

A 90-Minute Cancer Infusion Could Soon Be Cut to 5 Minutes—and Celltrion Wants to Lead It

Celltrion has applied for EMA approval of Herzuma SC, a new breast cancer treatment, enhancing drug delivery and patient convenience.

Mediogen Publishes a Study in the Journal of Functional Foods on Improving Periodontal Disease

Mediogen's study shows two probiotic strains improve gum health and protect bone, aiming for global oral health market approval.

Stem Cells Grown in Body-like Environment Show Improved Therapeutic Effects: Key to Regenerative Medicine

KAIST researchers developed a new polymer-based culture technology that enhances stem cell growth and therapeutic efficacy in regenerative medicine.

K-Medical Tourism Targets Visitors from Russia and Central Asia Who Spend 40% More than Average

South Korea's medical tourism exceeds 2 million visitors, targeting high-spending tourists from Russia and Central Asia through promotional campaigns.

CG Bio Group Launches Acellular Dermal Matrix-based Product Reallo Inject Fine

CG Bio launches Reallo Inject Fine, an acellular dermal matrix product, enhancing usability for medical professionals and expanding applications.

Ceragem Launches Global Standard for AI Home Healthcare, Accelerates Data Platform Push

Ceragem's new ISO/IEC report sets international standards for integrating home healthcare devices, focusing on user well-being and safety.

Hugel Participates AMWC ASIA & TDAC 2026 at the Taipei International Convention Center, Taiwan

Hugel targets Taiwan's aesthetic market, showcasing products at AMWC ASIA & TDAC 2026, while expanding in Indonesia with educational programs.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

Top News

- Our Sponsors Ad -

Follow us